Page 173

APPENDIX B

Public Session Agendas

Committee on the Elimination of Tuberculosis in the United States

FIRST COMMITTEE MEETING
March 8–9, 1999


Please refer to the page image for an unflawed representation of this content.

March 8 (closed meeting)

6:00 p.m.

Introduction and Overview

Bias Discussion

Clyde Behney will be leading the bias discussion.

7:00 p.m.

Dinner

March 9

8:00 a.m.

Welcome and Introductions

8:15 a.m.

Tuberculosis in the United States

Sponsor's Goals

Overview of U.S. Tuberculosis Epidemiology

Organization of U.S. Tuberculosis Control

Foreign-Born Tuberculosis in the United States

Ken Castro and Ida Onorato, CDC

Ken Castro is the Director of the Division of Tuberculosis Elimination at the Centers for Disease Control and Prevention and will probably present the material on the Centers for Disease Control and Prevention goals for the study and on the organization of tuberculosis in the United States. Ida



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 173
Page 173 APPENDIX B Public Session Agendas Committee on the Elimination of Tuberculosis in the United States FIRST COMMITTEE MEETING March 8–9, 1999 Please refer to the page image for an unflawed representation of this content. March 8 (closed meeting) 6:00 p.m. Introduction and Overview Bias Discussion Clyde Behney will be leading the bias discussion. 7:00 p.m. Dinner March 9 8:00 a.m. Welcome and Introductions 8:15 a.m. Tuberculosis in the United States Sponsor's Goals Overview of U.S. Tuberculosis Epidemiology Organization of U.S. Tuberculosis Control Foreign-Born Tuberculosis in the United States Ken Castro and Ida Onorato, CDC Ken Castro is the Director of the Division of Tuberculosis Elimination at the Centers for Disease Control and Prevention and will probably present the material on the Centers for Disease Control and Prevention goals for the study and on the organization of tuberculosis in the United States. Ida

OCR for page 173
Page 174 Onorato is the Chief of the Surveillance, Epidemiology and Investigations Branch, in the Tuberculosis Division and will be presenting on the U.S. Tuberculosis epidemiology and foreign-born Tuberculosis in the United States. In previous discussions I have asked them to avoid encyclopedic “data dumps” and to try to highlight what they see as the key issues for the committee. 10:45 a.m. Break 11:00 a.m. TB Research Ann Ginsberg, National Institutes of Health Dr. Ginsberg is the program officer for Tuberculosis projects at the National Institute of Allergy and Infectious Diseases, National Institutes of Health. I have asked her to provide an overview of Tuberculosis research in general, not just what is happening in the National Institutes of Health. I also asked her to avoid an encyclopedic list but to provide a sense of the research priorities, whether work is under way in that area, and where there are research gaps. 11:30 a.m. U.S. Role in Global Tuberculosis Amy Bloom, U.S. Agency for International Development Dr. Bloom is a Centers for Disease Control and Prevention assignee at the U.S. Agency for International Development providing technical support in the Health and Nutrition Division. AID has just recently allocated funds for Tuberculosis program support and has provided limited support to the World Health Organization and I asked her to outline this for the committee.

OCR for page 173
Page 175 Bess Miller, Centers for Disease Control and Prevention Dr. Miller is Assistant Director for Science in the Tuberculosis Division at Centers for Disease Control and Prevention. She will be presenting briefly in this section on an effort by the World Health Organization to develop a global action plan for tuberculosis. Centers for Disease Control and Prevention is involved in and supports this effort. 12:00 p.m. Information Needs and Sources Commissioned Studies Invited Expert Presentations Site Visits 12:45 p.m. Adjourn Public Session 1:00 p.m. (closed meeting) Committee Planning Future Meetings 3:00 p.m. Adjourn FIRST WORKSHOP June 7–8, 1999 Please refer to the page image for an unflawed representation of this content. PUBLIC AGENDA Monday, June 7 8:30 a.m. 10-Year Review of the Strategic Plan by ACET Charles Nolan, Advisory Committee for the Elimination of Tuberculosis 9:30 a.m. Human Rights, Social and Legal Considerations Lawrence Gostin, Georgetown University Law Center 10:30 a.m. Break

OCR for page 173
Page 176 10:45 a.m. Population Specific Issues Tuberculosis Elimination at the United States-Mexico Border Miguel Escobedo, Texas Department of Public Health Tuberculosis Elimination in Migrant and Seasonal Workers Deliana Garcia, Migrant Clinicians Network Tuberculosis Elimination in the Homeless/ Marginally Housed Andrew Moss, University of California at San Francisco 12:15 p.m. Lunch 1:00 p.m. Case Studies Tuberculosis Elimination, the New York Experience Paula Fujiwara, New York City Department of Health Impact of Directly Observed Therapy Stephen Weis, University of North Texas Health Science Center at Fort Worth Tuberculosis in the District of Columbia Michael Richardson, Medical Society of DC TB Elimination in Low-Incidence Areas Carol Poszik, South Carolina Department of Health and Environmental Control 3:00 p.m. Break 3:20 p.m. Contact Investigations and Outbreaks Expanded Contact Investigations Nancy Dunlap, University of Alabama at Birmingham. Managing Tuberculosis Outbreaks Ida Onorato, Centers for Disease Control and Prevention 4:40 p.m. Employee Health and Institutional Transmission Revised OSHA Regulations Amanda Edens, Occupational Safety and Health Administration

OCR for page 173
Page 177 Staff Track Eugene McCray, Centers for Disease Control and Prevention 6:00 p.m. Adjourn Tuesday, June 8 8:00 a.m. Tuberculosis in the Foreign Born Legal Issues in Immigration Sophia Cox, Immigration and Naturalization Service Tuberculosis Screening of Immigrants Nancy Binkin, Centers for Disease Control and Prevention Tuberculosis Elimination (Screening and Prevention) Among Immigrants in the United States Charles Nolan, Seattle-King County Department of Public Health 9:30 a.m. General Discussion and Questions 10:00 a.m. Break 10:15 a.m. Economic Issues Costs of Tuberculosis Zachary Taylor, Centers for Disease Control and Prevention Securing Funding for Tuberculosis Elimination Tim Westmoreland, Georgetown University Law Center 11:35 a.m. Modeling Tuberculosis Elimination Sally Blower, University of California at San Francisco 12:00 p.m. Adjourn

OCR for page 173
Page 178 THIRD MEETING August 17–19, 1999 Please refer to the page image for an unflawed representation of this content. Tuesday, August 17 U.S. Role in Global Tuberculosis Control 8:30–9:30 a.m. Current U.S. Activities in Global Tuberculosis Control Nancy Binkin, Division of Tuberculosis Elimination 9:30–10:30 a.m. A World Health Organization Perspective on the U.S. Role in Global Tuberculosis Control Arata Kochi, World Health Organization 10:30 a.m. Break 10:45–11:45 a.m. A Nongovernmental Organization Perspective Hans Rieder, International Union Against Tuberculosis and Lung Disease 11:45–12:30 p.m. General Discussion 12:30–1:30 p.m. Lunch Training and Education Issues in Tuberculosis Control 1:30–2:15 p.m. Strategic Plan for Training and Education in Tuberculosis Andrea Green-Rush, Francis J. Curry National Tuberculosis Center, University of California at San Francisco 2:15–3:00 p.m. Centers for Disease Control and Prevention Activities in Tuberculosis Training and Education Wanda Walton, Division of Tuberculosis Elimination 3:00–3:15 p.m. Break

OCR for page 173
Page 179 3:15–4:00 p.m. Innovative Programs in Health Communication Scott Ratzan, Academy for Educational Development 4:00–4:45 p.m. Risk Communication Julie Downs, Carnegie Mellon University 4:45–5:30 p.m. General Discussion Wednesday, August 18 8:30 a.m.–5:30 p.m. Closed Session Thursday, August 19 8:30 a.m.–1:00 p.m. Closed Session FIFTH MEETING January 11–13, 2000 Please refer to the page image for an unflawed representation of this content. Tuesday, January 11 8:30 a.m.–12:30 p.m Roundtable Discussion on the Practical, Legal, and Ethical Issues Related to: 8:30 a.m.–8:45 a.m. Introductions T. Alexander Aleinikoff, Professor of Law, Georgetown University Mark Barnes, Proskauer Rose LLP Angela M. Bean, Angela M. Bean and Associates Lawyers Kenneth Castro, Centers for Disease Control and Prevention Susan T. Cookson, Centers for Disease Control and Prevention Sophia Cox, Adjudications Officer, Immigration and Naturalization Service Michael Garotte, Consular Officer, Visa Section, U.S. Department of State

OCR for page 173
Page 180 Andrew I. Schoenholtz, Director of Law and Policy Studies, Georgetown University Douglas Shenson, M.D. M.P.H., Director, Human Rights Clinic, Montefiore Medical Center, North Central Bronx Hospital 8:45 a.m.–10:15 a.m. Can tuberculin skin testing be conducted for immigrants to the United States in their country of origin? Can a B3 category be created for individuals with a positive tuberculin skin test and people in this category be processed much as category B1 and B2 immigrants are processed now? Can the health screening requirements differ on the basis of country of origin? Is the estimated prevalence of infection in other countries a suitable criterion for deciding who should be tuberculin tested prior to arrival? Should immigrants from Mexico be tuberculin skin tested prior to immigration, since individuals born in Mexico account for the greatest number of foreign-born cases, even though the official estimates of the prevalence of infection is not above the global median? 10:15 a.m.–10:30 a.m. Break 10:30 a.m.–12:30 p.m. Can the completion of tuberculosis screening for immigrants with Class B waivers be tied to the right to permanent residence in the United States? Should the completion of tuberculosis screening for immigrants with Class B waivers be tied to the right to permanent residence in the United States? Should the completion of treatment for latent infection be legally mandated for individuals with the highest risk for developing tuberculosis?

OCR for page 173
Page 181 Can/should individuals, other than immigrants and refugees, entering the United States for long periods of time, such as students, trainees, workers, and their families, be required to have screening for tuberculosis? Could the completion of tuberculosis screening be made the responsibility of the sponsor of the students, trainees, workers, and their families? 12:30 p.m. Adjourn the Public Session 12:30–1:30 p.m. Lunch 1:30–5:30 p.m. Executive Session (Closed to the Public) Wednesday, January 12 8:30 a.m.–5:30 p.m. Executive Session (Closed to the Public) Continue Review of Report Draft Thursday, January 13 8:30 a.m.–3:30 p.m. Executive Session (Closed to the Public) Continue Review of Report Draft Discuss Report Release and Dissemination Plan